New ‘cocktail’ drug could benefit up to 45 per cent of patients with Duchenne muscular dystrophy — ScienceDaily
A new “cocktail” drug being developed at the University of Alberta could provide an effective and economical treatment to lessen symptoms for up to 45 per cent of patients with…
